A rural Ozarks hospital is closing a dangerous gap in medical detox care, delivering medication and a virtual recovery appointment within 72 hours of an opioid overdose or withdrawal visit. For patients across this part …
A new clinical trial using GLP-1 medication at the University of Washington could change how physicians approach alcohol detox treatment and withdrawal management. Researchers are testing brenipatide, a novel GLP-1/GIP made by Eli Lilly, to …
A Stanford Medicine clinical trial has found that low-dose buprenorphine, a cornerstone of medication-assisted treatment for opioid use disorder, may also dramatically extend the anti-suicidal effects of ketamine infusions in patients with major depressive disorder. …
A newly approved, high-dose naloxone nasal spray has secured a spot on the formulary of a major national health plan, a development with direct relevance for anyone going through opioid detox or supporting a loved …
A landmark final rule from the Drug Enforcement Administration (DEA), published June 9, 2026, formally eliminates the long-standing X-waiver requirement for medication-assisted treatment of opioid use disorder. It also extends the window for administering injectable …
800-671-4304
